These data clearly suggest that, when integrated into panels of other tumor markers (including e.g. CA-19-9), the analysis of serum BSP concentrations might represent a novel tool for the diagnosis of pancreatic cancer. This evidence concerns the gene IBSP and pancreatic neoplasm.